CELC (Celcuity) Total Operating Expense: $186.57 Mil (TTM As of Mar. 2026)


CELC Celcuity Inc CELC
26 GF Score
Price $107.95
! 2 Warning Signs
View Full Analysis

What is Celcuity Total Operating Expense?

Celcuity CELC +3.22% 26 Total Operating Expense is $186.57 Mil as of Mar. 2026. GuruFocus rates CELC with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

Celcuity's Total Operating Expense for the three months ended in Mar. 2026 was $50.51 Mil. Celcuity's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $186.57 Mil.


Celcuity Total Operating Expense Related Terms


Celcuity Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Celcuity's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celcuity Total Operating Expense Chart

Celcuity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.36 39.39 66.23 113.27 172.19

Celcuity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.13 44.01 42.85 49.20 50.51
CELC
26GF Score
Celcuity Inc CELC
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Celcuity Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $186.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $186.57 Mil mean?
Celcuity (CELC) has a Total Operating Expense of $186.57 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Celcuity and its competitors.
Is Celcuity's Total Operating Expense too high?
Celcuity's current Total Operating Expense is $186.57 Mil. Overall, Celcuity has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Celcuity's Total Operating Expense compare to ERAS and TNGX?
Celcuity's Total Operating Expense of $186.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Celcuity and its competitors. Celcuity's current Total Operating Expense is $186.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celcuity stock overvalued right now?
Celcuity (CELC) has a current Total Operating Expense of $186.57 Mil. The current Total Operating Expense is $186.57 Mil. Celcuity's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Celcuity (CELC), the current Total Operating Expense is $186.57 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Celcuity Business Description

Other Exchanges 7VR:Germany
Address 16305 36th Avenue North, Suite 100, Minneapolis, MN, USA, 55446
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.
26GF Score

Get the complete analysis for CELC

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$107.95
Price